The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lenalidomide Accord 25 mg hard capsules

Accord Healthcare S.L.U.EU/1/18/1316/011

Main Information

Trade NameLenalidomide Accord 25 mg hard capsules
Active SubstancesLenalidomide
Dosage FormCapsule, hard
Licence HolderAccord Healthcare S.L.U.
Licence NumberEU/1/18/1316/011

Group Information

ATC CodeL04AX04 lenalidomide


License statusAuthorised
Licence Issued20/09/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable ListLenalidomide 25mg Capsules
Interchangeable List CodeIC0125-022-001
Interchangeable List DocumentPDF of Interchangeable List
« Back